A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace


genoTOR™ characterises an individual’s genetic profile linked to mTOR-regulated signalling pathways, mechanisms known to affect the risk of Alzheimer's and dementia. It is now widely accepted that the pathogenesis of Alzheimer’s disease involves defects in cell cycle regulation. Many cellular processes are controlled by the mTOR pathway and differentially expressed mTOR pathway genes may regulate key functions linked to Alzheimer’s disease.

genoTOR™calculates a SNP burden score for 21 different pathways associated with mTOR, providing insight into Alzheimer's disease subjects who phenotypically show similar symptoms, but genotypically may be quite different.